marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q2
added 08-14-2024
Seelos Therapeutics Cash Flow 2011-2024 | SEEL
Annual Cash Flow Seelos Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-23.9 M | -61.6 M | - | - | - | - | - | -13.1 M | -22.6 M | - | - | -12.3 M | -9.72 M |
Depreciation & Amortization |
- | - | - | - | - | 41 K | 117 K | 289 K | 300 K | 170 K | 77 K | 203 K | 602 K |
Accounts Payables |
16.4 M | 3.63 M | 1.69 M | 1.89 M | 796 K | 235 K | 58 K | 960 K | 1.58 M | 860 K | 926 K | 2.28 M | 1.14 M |
Accounts Receivables |
763 K | - | - | - | - | - | - | - | 519 K | 678 K | 59 K | 678 K | 327 K |
Total Inventories |
- | - | - | - | - | - | - | - | 469 K | 275 K | 336 K | - | 136 K |
All numbers in USD currency
Quarterly Cash Flow Seelos Therapeutics
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | -4.64 M | - | - | - | -10.3 M | - | -48.5 M | - | -17 M | - | -30.7 M | - | -11.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -6.12 M | - | -21.3 M | -14.7 M | -6.13 M | - | - | - | -192 K | - | - | - | - | - | - | - | -5.16 M | - | -7.3 M | -4.51 M | -2.43 M |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 13 K | - | 98 K | 77 K | 56 K | - | 217 K | 145 K | 72 K | - | 224 K | 149 K | 74 K | - | 102 K | 40 K | 20 K | - | 57 K | 41 K | 21 K | - | 510 K | 196 K | 98 K | - | 509 K | 417 K | 245 K |
Accounts Payables |
15.7 M | 15.3 M | 16.4 M | 9.32 M | 6.44 M | 5.96 M | 3.63 M | 5.95 M | - | 2.13 M | 1.69 M | 3.4 M | 1.04 M | 1.63 M | 1.89 M | 1.89 M | 1.89 M | 3.28 M | 796 K | 796 K | 796 K | 796 K | 2.22 M | 2.22 M | 2.22 M | 2.22 M | 58 K | 58 K | 58 K | 58 K | 763 K | 686 K | 686 K | 686 K | 1.58 M | 1.58 M | 1.58 M | 1.58 M | 860 K | 860 K | 860 K | 860 K | 926 K | 926 K | 926 K | 926 K | 2.28 M | 2.28 M | 2.28 M | 2.28 M | 1.05 M | 1.14 M | 1.14 M | 1.14 M |
Accounts Receivables |
188 K | 968 K | 763 K | 221 K | 431 K | 793 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 530 K | 398 K | 687 K | 688 K | 519 K | 519 K | 519 K | 519 K | 678 K | 678 K | 678 K | 678 K | 59 K | 59 K | 59 K | 59 K | 652 K | 653 K | 653 K | 678 K | 21 K | 327 K | 327 K | 327 K |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 764 K | 800 K | 778 K | 405 K | 469 K | 469 K | 469 K | 469 K | 275 K | 275 K | 275 K | 275 K | 336 K | 336 K | 336 K | 336 K | - | - | 427 K | 303 K | 136 K | - | 136 K | 136 K |
All numbers in USD currency